Cover Image

Screening of high-risk groups for breast and ovarian cancer in Europe: a focus on the Jewish population

Karen L. Belkic, Miri Cohen, Marcela Marquez, Miriam Mints, Brigitte Wilczek, Anne H. Berman, Enrique Castellanos, Martha Castellanos
  • Karen L. Belkic
    Institute of Oncology-Pathology, Karolinska Institute and Hospital, Stockholm; School of Community and Global Health, Claremont Graduate University, Claremont; Institute for Prevention Research, The Keck School of Medicine of the University of Southern California, Los Angeles, Sweden | Karen.Belkic@ki.se
  • Miri Cohen
    Department of Gerontology, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel
  • Marcela Marquez
    School of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico
  • Miriam Mints
    Department of Obstetrics and Gynecology, Karolinska Institute and Hospital, Stockholm,, Sweden
  • Brigitte Wilczek
    Department of Mammography, Unilabs AB, Sankt Gorans Hospital, Stockholm, Sweden
  • Anne H. Berman
    Department of Clinical Neurosciences, Karolinska Institute and Hospital, Stockholm, Sweden
  • Enrique Castellanos
    Department of Oncology-Pathology, Karolinska Institute and Hospital, Stockholm, Sweden
  • Martha Castellanos
    Stockholm Ambulatory Care Center, SaltsjoBana, Sweden

Abstract

Low breast cancer screening rates are often found among ethnic minority groups and those born outside the host country. This is of particular concern for high-risk groups, who should benefit from ongoing trials aimed at optimizing screening strategies for breast, as well as ovarian cancer. Both of these issues are germane for Jewish women in Europe. We systematically review the literature concerning breast cancer early detection practices (BCEDP) among Jewish women, and examine European surveillance studies of high-risk for breast and/or ovarian cancer that had imaging in the surveillance protocol, in order to assess the likelihood of adequately including women from minority ethnic groups. No studies were found about BCEDP among Jewish women in Europe. Twenty-one research groups from Israel or the US addressed BCEDP among Jewish women. Some Jewish women in the US and Israel, including recent immigrants, are under-screened. Twenty-four research groups reported imaging surveillance of women at increased risk for breast and/or ovarian cancer in Europe. There was a clear benefit to magnetic resonance imaging and/or more intensive screening for women with increased breast cancer risk. Some of these surveillance studies considered ethnic minority groups at high risk, including Jewish women, but none provided adequate outreach to ensure that these groups were included in their programs. The specific screening needs of Jewish and other high-risk ethnic minority groups in Europe have not been met regarding breast and ovarian cancer. A European-wide, population-based approach is suggested, with cultural sensitivity being vital for these efforts.

Keywords

Breast cancer - Ovarian cancer - Early detection - Imaging surveillance - BRCA mutations - Cultural sensitivity

Full Text:

FULL TEXT
Submitted: 2011-12-13 09:09:31
Published: 2011-12-14 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
611

Views:
FULL TEXT
173

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2011 Karen L. Belkic, Miri Cohen, Marcela Marquez, Miriam Mints, Brigitte Wilczek, Anne H. Berman, Enrique Castellanos, Martha Castellanos

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185